Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - CASI Pharmaceuticals, Inc. | v462424_ex31-2.htm |
| 10-K - FORM 10-K - CASI Pharmaceuticals, Inc. | v462424_10k.htm |
| EX-23.1 - EXHIBIT 23.1 - CASI Pharmaceuticals, Inc. | v462424_ex23-1.htm |
| EX-32.1 - EXHIBIT 32.1 - CASI Pharmaceuticals, Inc. | v462424_ex32-1.htm |
| EX-31.1 - EXHIBIT 31.1 - CASI Pharmaceuticals, Inc. | v462424_ex31-1.htm |
Exhibit 32.2
CERTIFICATION BY PRINCIPAL ACCOUNTING OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of CASI Pharmaceuticals, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Sara B. Capitelli, as Vice President, Finance & Principal Accounting Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of` the Sarbanes-Oxley Act of 2002, to the best of my knowledge, that:
| (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company |
This certificate is being made for the exclusive purpose of compliance by the Principal Accounting Officer of the Company with the requirements of Section 906 of the Sarbanes-Oxley Act of 2002, and may not be used by any person or for any reason other than as specifically required by law.
| /s/ Sara B. Capitelli | ||
| March 31, 2017 | Sara B. Capitelli Principal Accounting Officer |